HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2054702Generated: October 26, 2026
Isradipine → 2-Acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester
https://huagongshe.com/reaction/2054702
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Isradipine | HCID 3784 | — |
| Reactant | Methyl acetoacetate | HCID 7757 | — |
| Reactant | Piperidine | HCID 8082 | — |
| Reactant | 2,1,3-Benzoxadiazole-4-carbaldehyde | HCID 10290873 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Solvent | Diisopropyl Ether | HCID 7914 | — |
| Product | 2-Acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester | HCID 53433213 | — |
Reaction Steps
To achieve the afore-mentioned objects, the present invention provides for a process for the manufacture of the Isradipine which, involves two steps. In the first step 2,1,3-benzoxadiazole-4-carboxaldehyde is reacted with methyl acetoacetate in the presence of acetic acid and piperidine in diisopropyl ether. The product 2-acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester is isolated and purified to get substantially high purity product with less than 0.3% 2,1,3-benzoxadiazole-4-carboxaldehyde content present in the purified product. In the second step the purified intermediate 2-acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester is reacted with isopropyl-β-aminocrotonate in ethanol at 25 to 35° C. The crude Isradipine is crystallised from ethanol to get pure Isradipine having substantially higher purity and containing lower amount of the symmetrical ester isomers (III) and (IV).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07329756B2 |
|---|
| Source dataset | uspto-grants-2008_02 |
|---|
| ORD ID | ord-391dc78fba9444bda56964b252ebf9ae |
|---|
| Source note | uspto-grants-2008_02 |
|---|